DCT

1:22-md-03038

In re: Ozempic (Semaglutide) Patent Litigation

General
Filed
08/05/22
Cause of ActionPatent Infringement
SectorMech Eng, Manuf
Status
Closed (09/11/24)
Patent Owner
NPE (L)
Nature of Suit835 ANDA
Judge
Period
PO Win Rate
08/22/22 - 12/13/24
41%
Plaintiff
Defendant
Attorney
Name
Ratings
No Defendant Attorneys
No Attorneys